<?xml version="1.0" encoding="UTF-8"?>
<p>Nevertheless, some drugs have already been used in several clinical trials, as summarized in 
 <xref rid="microorganisms-08-00085-t001" ref-type="table">Table 1</xref>. Most of them regard the use of antimalarial drugs against HIV infection, but some of them failed, and for others, the final results are not available. Although these outcomes can seem discouraging, at least four clinical trials deserve attention: The one on the use of AS against HCMV, with particular regard to the drug-resistant strains, the one targeting CHIKV with CQ, and the other two very innovative and ongoing trials on the use of AS against HPV for the treatment of anal and cervical intraepithelial high-grade neoplasia.
</p>
